Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: levaquin / lisinopril / clonidine / hydralazine / terazosin / lasix / hytrin / amlodipine / ibuprofen / celexa / bactrim / relpax attending: chief complaint: transfer for cath and asa desensitization major surgical or invasive procedure: 1. cardiac catheterization with drug eluting stent to left circumflex artery - attending physician: , md history of present illness: 57yo f pmhx morbid obesity, dm, htn, hld, asthma, history of asa allergy (induced cough, worsened asthma symptoms) who was initially admitted to w l arm pain, found to have lcx lesion, now transferred to for cardiac catheterization and asa desensitization protocol. per patient report, on day of admission to , she developed acute onset l arm pain in the setting of doing her morning stretches, described as "severe", exertional, without associated chest pain, shortness of breath. given comorbidities, coronary cta was ordered to better risk-stratify based on her coronary disease, which was reportedly abnormal (no report available at this time). this prompted cardiac catherization that demonstrated 3vd w mild rca and lad disease, as well as critical mid lcx lesion. patient was transferred for further intervention. . at patient underwent cardiac cath via l radial, underwent placement of des to mid-cx without complication. given history of reported asa allergy (1 year ago worsening wheezing / asthma symptoms in past after 3d aspirin, with symptom improvement after asa cessation), patient was transferred to ccu for post-cath for asa desensitization protocol. . on arrival to the floor, patient was without complaint, denied shortness of breath, chest pain, arm pain. denied dyspnea on exertion, paroxysmal nocturnal dyspnea, orthopnea, palpitations, syncope or presyncope. past medical history: 1. cardiac risk factors: +diabetes, +dyslipidemia, +hypertension 2. cardiac history: - cabg: - percutaneous coronary interventions: - pacing/icd: 3. other past medical history: - asthma - thrombocytosis on hydroxyurea - esophagitis w schatski's ring - cervicalgia - morbid obesity social history: lives in w husband. retired teacher. denies tobacco, etoh, illicits. family history: father w h/o htn, mi, cva. mother w h/o htn, aaa, lymphoma. physical exam: admission physical examination: vs: 97.3 71 120/56 11 97%ra general: nad, comfortable heent: ncat, perrl, eomi neck: supple, unable to assess jvp 2/2 habitus cardiac: rrr, normal s1, s2. no m/r/g. lungs: resp unlabored, no accessory muscle use, quiet breath sounds bilaterally w/o crackles, wheezes or rhonchi abdomen: soft, obese, nontender extremities: no c/c/e. right: dp 2+ pt 2+ left: dp 2+ pt 2+ . discharge physical exam: vs: 98.2 77 113/65 15 99%ra general: nad, comfortable heent: ncat, perrl, eomi neck: supple, unable to assess jvp 2/2 habitus cardiac: rrr, normal s1, s2. no m/r/g. lungs: resp unlabored, no accessory muscle use, quiet breath sounds bilaterally w/o crackles, wheezes or rhonchi abdomen: soft, obese, nontender extremities: no c/c/e. right: dp 2+ pt 2+ left: dp 2+ pt 2+ pertinent results: admission labs: . 07:57pm blood wbc-9.2 rbc-3.08* hgb-8.7* hct-26.8* mcv-87 mch-28.2 mchc-32.3 rdw-15.8* plt ct-457* 07:57pm blood neuts-72.2* lymphs-21.7 monos-3.4 eos-2.2 baso-0.5 07:57pm blood glucose-107* urean-11 creat-0.8 na-141 k-3.2* cl-100 hco3-30 angap-14 07:57pm blood calcium-8.8 phos-3.7 mg-1.9 . pertinent labs: . 05:31am blood ck-mb-3 . discharge labs: . 05:31am blood hct-31.6* plt ct-372 . micro/path: mrsa screen: negative . imaging/studies: . c.cath : final diagnosis: 1. three vessel coronary artery disease. 2. successful pci of the lcx with des. 3. aspirin desensitization immediately on arrival to ccu, then continue aspirin daily indefinitely. 4. plavix 75 mg daily. 5. integrilin iv gtt x 18 hours. 6. after discharge, the patient to follow up with dr. , medical cardiology. brief hospital course: 57yo f pmhx morbid obesity, dm, htn, hld, asthma, history of asa allergy (induced cough, worsened asthma symptoms) transfered for critical lcx lesion, now s/p transferred to icu for asa desensitization protocol. . active diagnoses: . # 3 vessel coronary artery disease s/p pci with stent: she was transferred to for evaluation and treatment of critical stenosis of her mid left circumflex coronary artery. on catheterization she was found to have significant 3-vessel disease (please see report for full details) and had placements of des to mid lcx lesion. she was treated with plavix, carvedilol, pravastatin, and integrillin and underwent aspirin desensitization as below. her course was otherwise unremarkable and she was discharged with follow-up appointments in cardiology and with her pcp. . # aspirin allergy/desensitization: this patient with significant history of allergies and atopy had a reported history of reactive airways secondary to aspirin in the past. following stent placement, treatment with aspirin became a priority and in consultation with the allergy and immunology team, she underwent a 6 hour desensitization protocol involving montelukast prior to initiation and frequent, escalating doses of aspirin with serial peak flow measurements and close monitoring on tele for possibility of developing a severe reaction. she was quite anxious during this testing but tolerated the protocol well without complications. she was discharged on aspirin and with instructions to seek urgent medical care if she developed concerning symptoms. . chronic diagnoses: . # htn: stable. she was continued on her home hctz and diltiazem. . # asthma / chronic cough: stable. in addition to the protocol medications, she was continued on her home advair, mucinex, and zyrtec. . # seasonal allergies: stable. she was continued on her home nasarel. . # dm: stable. she was continued on her standing nph and regular insulin sliding scale. . # thrombocytosis: stable with plt counts in the high 300's to mid 400's. her hydrea was held overnight on the day of admission and restarted on discharge. . # gerd: stable. she was continued on her home ranitidine. . transitional issues: . #this patient would likely benefit from an outpatient echo to assess her cardiac function in weeks . #she underwent aspirin desensitization protocol while admitted here. she was instructed to seek care from her pcp for minor symptoms or a local ed if her symptoms are more concerning with the possbility of transfer back to if warranted. medications on admission: zertec 10mg daily ranitidine 300mg mucinex 600mg clotrimazole suppositories 500mg twice weekly hctz 25mg kcl 10meq qid plavix 75mg daily insulin hydrea 500mg tid three days/week, 500mg two days/week advair 500/50 1 puff nasarel 2 sprays clobetasol prn carvedilol 25mg qid diltiazem 240mg daily pravastatin 20mg daily discharge medications: 1. zyrtec 10 mg capsule sig: one (1) capsule po once a day. 2. ranitidine hcl 300 mg capsule sig: one (1) capsule po twice a day. 3. mucinex 600 mg tablet extended release sig: one (1) tablet extended release po twice a day. 4. clotrimazole vaginal 5. hydrochlorothiazide 25 mg tablet sig: one (1) tablet po twice a day. 6. potassium chloride 10 meq tablet extended release sig: one (1) tablet extended release po qid (4 times a day). 7. clopidogrel 75 mg tablet sig: one (1) tablet po daily (daily). 8. aspirin 325 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). disp:*30 tablet, delayed release (e.c.)(s)* refills:*2* 9. hydrea 500 mg capsule sig: capsules po once a day: please take three times daily three days per week, and twice daily two days per week. . 10. fluticasone-salmeterol 500-50 mcg/dose disk with device sig: one (1) disk with device inhalation (2 times a day). 11. clobetasol topical 12. flunisolide nasal 13. carvedilol 25 mg tablet sig: two (2) tablet po twice a day. 14. diltzac er 240 mg capsule, extended release sig: one (1) capsule, extended release po three times a day. 15. pravastatin 20 mg tablet sig: one (1) tablet po hs (at bedtime). 16. nph insulin human recomb 100 unit/ml suspension sig: as directed units subcutaneous twice a day: 26 units in the morning and 12 units at night. 17. insulin regular human 100 unit/ml solution sig: as directed units injection twice a day: 10 units with breakfast and 14 units with dinner. discharge disposition: home discharge diagnosis: primary diagnosis: coronary artery disease, aspirin desensitization, asthma secondary diagnosis: diabetes, dyslipidemia, hypertension discharge condition: mental status: clear and coherent. level of consciousness: alert and interactive. activity status: ambulatory - independent. left arm pain free. discharge instructions: it was a pleasure taking care of you during your stay here at . you were admitted for left arm pain. a cardiac catheterization was performed via the left radial artery with placement of a drug eluting stent in your left circumflex coronary artery. your left arm pain subsequently resolved. given your history of wheezing and worsening of your asthma after prior aspirin therapy, you were admitted to the ccu after the procedure for aspirin densensitization. you were given increasing doses of aspirin until the goal of 325mg was given. your asthma was monitored with peak flow measurements and was stable throughout the desensitization. ***you will need to continue taking your aspirin every day without exception.*** if you miss more than three days of aspirin therapy you will need to be desensitized again. please do not stop taking your aspirin or plavix unless your cardiologist instructs you to do so. the following changes were made to your medication regimen: start aspirin 325mg daily your attending physician during your stay was dr. . followup instructions: please call to make an appointment with your pcp at within one - two weeks of discharge. please call to make an appointment with your cardiologist, dr. , within one month. you will need a repeat ekg and echocardiogram at this visit. md procedure: coronary arteriography using two catheters injection or infusion of platelet inhibitor left heart cardiac catheterization insertion of drug-eluting coronary artery stent(s) cranial or peripheral nerve graft insertion of one vascular stent excision of lingual thyroid percutaneous transluminal coronary angioplasty [ptca] procedure on single vessel diagnoses: coronary atherosclerosis of native coronary artery congestive heart failure, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled asthma, unspecified type, unspecified need for desensitization to allergens other and unspecified hyperlipidemia morbid obesity chronic diastolic heart failure long-term (current) use of aspirin 

Answer: The patient is high likely exposed to